Skip to content

Supplier News

McKesson, CVS sign new pact for Target Rx

McKesson, CVS sign new pact for Target Rx

McKesson Corp. announced a new distribution pact with CVS Health for Target pharmacies in updating its earnings outlook for fiscal 2016 and providing preliminary guidance for fiscal 2017.

TABS Group adopts new name

TABS Group adopts new name

Highlighting its acumen in consumer packaged goods (CPG) analytics, TABS Group has changed its name to TABS Analytics. TABS said the new name, which goes into effect immediately, better represents its mission to simplify and improve sales and marketing analytics for CPG companies.

Actress Rachel Bilson teams up with Chapstick

Actress Rachel Bilson teams up with Chapstick

Chapstick has signed up actress Rachel Bilson as the lip balm brand’s newest spokesperson. Pfizer Consumer Healthcare, the maker of Chapstick, said Monday that Bilson will appear in a marketing campaign to highlight the brand’s innovation and focus on the importance of skin care for lips.

Shire to acquire Baxalta in $32 billion deal

Shire to acquire Baxalta in $32 billion deal

Shire plc plans to buy Baxalta Inc., a biopharmaceutical company focused on orphan diseases and underserved conditions, in a cash and stock deal valued at $32 billion. Under the agreement, Baxalta shareholders will receive $18 in cash and 0.

General Mills buys EPIC Provisions

General Mills buys EPIC Provisions

General Mills Inc. has acquired EPIC Provisions, a premium meat snacks company based in Austin, Texas. Terms of the agreement weren’t disclosed. Plans call for EPIC to operate under General Mills’ Annie’s business and remain in its Austin headquarters.

Valeant appoints interim CEO

Valeant appoints interim CEO

Valeant Pharmaceuticals International Inc. has named former chief financial officer Howard Schiller as interim chief executive officer, effective immediately. Valeant said Wednesday that it appointed Schiller to the interim role because chairman and CEO J.

Mylan, Teva release generics of Ortho Tri-Cyclen Lo

Mylan, Teva release generics of Ortho Tri-Cyclen Lo

Mylan N.V. and Teva Pharmaceutical Industries Ltd. have rolled out norgestimate/ethinyl estradiol tablets, a birth control pill, in the United States. The companies said Tuesday that their products are generic versions of Janssen Pharmaceuticals Inc.’s Ortho Tri-Cyclen Lo tablets.

FDA approves Zyvox generic from Glenmark

FDA approves Zyvox generic from Glenmark

Glenmark Pharmaceuticals Inc. USA has been granted approval from the Food and Drug Administration for linezolid tablets 600 mg, an antibiotic. Glenmark said its linezolid product is a therapeutic equivalent of Zyvox tablets 600 mg from Pfizer Inc.